Direkt zum Inhalt
Merck

Fortfahren mit

32476

Selamectin

VETRANAL®, analytical standard

Synonym(e):

(5Z)-25-Cyclohexyl-4′-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-avermectin A1a

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis
10 mg
Warenkorb auf Verfügbarkeit prüfen
€ 396,00

Über diesen Artikel

Empirische Formel (Hill-System):
C43H63NO11
CAS-Nummer:
Molekulargewicht:
769.96
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24

€ 396,00


Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


grade

analytical standard

Quality Level

product line

VETRANAL®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

O/N=C1[C@]2([H])[C@]3(O)[C@@](C(O[C@@H]4C[C@]5(O[C@@](C/C=C(C)/[C@@H](O[C@]6([H])C[C@@H]([C@@H](O)[C@H](C)O6)OC)[C@@H](C)/C=C/C=C3\CO2)([H])C4)O[C@H](C7CCCCC7)[C@@H](C)CC5)=O)([H])C=C\1C

InChI

1S/C43H63NO11/c1-24-11-10-14-30-23-50-40-36(44-48)27(4)19-33(43(30,40)47)41(46)52-32-20-31(16-15-25(2)38(24)53-35-21-34(49-6)37(45)28(5)51-35)54-42(22-32)18-17-26(3)39(55-42)29-12-8-7-9-13-29/h10-11,14-15,19,24,26,28-29,31-35,37-40,45,47-48H,7-9,12-13,16-18,20-23H2,1-6H3/b11-10+,25-15+,30-14+,44-36-/t24-,26-,28-,31+,32-,33-,34-,35-,37-,38-,39-,40+,42+,43+/m0/s1

InChI key

AFJYYKSVHJGXSN-XHKIUTQPSA-N

General description

Selamectin (25-cyclohexyl-25-de(1-methylpropyl)-5-deoxy-22,23-dihydro-5-(hydroxyimino)-avermectin B1 monosaccharide) is a novel endectocide. It is an anti-parasitic agent and has a unique combination of safety and efficacy both in cats and dogs following both topical and oral administration. It prevents ticks and fleas, immature heartworms, ascarids and intestinal hookworms. It can be easily tolerated even at higher dosages than 22,23-dihydroavermectin B1a (DHAVM).[1]

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
SML26631611729Y0000814
Selamectin United States Pharmacopeia (USP) Reference Standard

USP

1611729

Selamectin

vibrant-m

Y0000814

Selamectin

grade

analytical standard

grade

-

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

format

neat

format

-

format

neat

format

neat

product line

VETRANAL®

product line

-

product line

-

product line

-

application(s)

forensics and toxicology
pharmaceutical (small molecule)

application(s)

-

application(s)

pharmaceutical

application(s)

pharmaceutical (small molecule)

storage temp.

2-8°C

storage temp.

−20°C

storage temp.

-

storage temp.

2-8°C

shelf life

limited shelf life, expiry date on the label

shelf life

-

shelf life

-

shelf life

-


Still not finding the right product?

Explore all of our products under Selamectin


hcodes

Hazard Classifications

Aquatic Chronic 4

Lagerklasse

11 - Combustible Solids

wgk

WGK 3



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Selamectin: a novel broad-spectrum endectocide for dogs and cats
Bishop, B. F., et al.
Veterinary Parasitology, 91 (3), 163-176 (2000)
Chandan Seth et al.
PloS one, 11(12), e0168170-e0168170 (2016-12-16)
The WNT-TCF signaling pathway participates in adult tissue homeostasis and repair, and is hyperactive in a number of human diseases including cancers of the colon. Whereas to date there are no antagonists approved for patient use, a potential problem for
Alice Melotti et al.
EMBO molecular medicine, 6(10), 1263-1278 (2014-08-22)
Constitutive activation of canonical WNT-TCF signaling is implicated in multiple diseases, including intestine and lung cancers, but there are no WNT-TCF antagonists in clinical use. We have performed a repositioning screen for WNT-TCF response blockers aiming to recapitulate the genetic



Global Trade Item Number

SKUGTIN
32476-10MG04061826711736

Questions

Reviews

No rating value

Active Filters